ShockWave Medical acquisisce Neovasc in un'operazione iniziale da 100 milioni di dollari; le azioni di Neovasc salgono | MarketScreener
![A clinical trial to compare faricimab with aflibercept in people with neovascular age-related macular degeneration. (Tenaya) A clinical trial to compare faricimab with aflibercept in people with neovascular age-related macular degeneration. (Tenaya)](https://roche63-h.assetsadobe2.com/is/image//content/dam/patient-platform/ctd-designs/global-platform/4751%20-%20Ashfield,%2026.%20Tenaya%20infographic_1122843_LLv4-images.zip.jpg?$pp-text-image$)
A clinical trial to compare faricimab with aflibercept in people with neovascular age-related macular degeneration. (Tenaya)
![Gli azionisti di Neovasc approvano la proposta di acquisizione da parte di Shockwave Medical | MarketScreener Gli azionisti di Neovasc approvano la proposta di acquisizione da parte di Shockwave Medical | MarketScreener](https://www.zonebourse.com/images/actions/th/TCN_IT_SScreener2.gif)